CSS

CSS is a prominent Swiss health insurer committed to advancing healthcare through digital innovation. Through its venture capital arm, SwissHealth Ventures, CSS invests in European start-ups that offer digital health solutions relevant to the Swiss healthcare market. The focus areas include telemedicine, early detection diagnostics, and digital tools for managing chronic illnesses. Investments typically range from 0.5 to 4 million Swiss francs, with CSS usually taking less than a 20% stake in each company.

In 2020, CSS became the first health insurer in Switzerland to enter into corporate venturing, aiming to develop new technologies and business models in collaboration with innovative start-ups. This initiative seeks to provide clients with early access to new treatment forms, products, and services, fostering a more integrated healthcare system. Notable investments include Flow Neuroscience, Humanoo, and Resmonics, each contributing to advancements in mental health, wellness, and chronic disease management.

Through these strategic investments, CSS demonstrates its commitment to shaping the future of healthcare by supporting innovations that empower individuals to stay healthy, recover effectively, and manage illnesses more efficiently. The company's approach combines financial backing with technical and market expertise, leveraging its strong network within the Swiss healthcare system to facilitate rapid market access for its portfolio companies.